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ABSTRACT
IDENTIFYING SORTASE A VARIANTS WITH HIGHER CATALYTIC EFFECIENCY

Muna Suliman
A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2012

Director: Dr. William A Barton
Associate Professor, Department of Biochemistry and Molecular Biology

In the past two decades, the field of protein engineering has evolved rapidly to include
new genetic and chemical techniques to alter protein function. Protein engineering seeks to
improve enzyme properties through powerful methods that specifically incorporate novel or
improved function in proteins. One such method is protein ligation, which is used to selectively
link synthetic and recombinant polypeptides. Due to the limitations of current protein labeling
techniques, simple site-specific modification methods remain in high demand. Use of enzymebased labeling has been the focus of various studies because of its substrate specificity. Sortasemediated transpeptidation is one approach that has been well documented.
Staphylococcus aureus sortase A (SrtAstaph), a membrane-anchored cysteine
transpeptidase present in gram-positive bacteria, covalently anchors virulence-associated
surface proteins to the peptidoglycan cross bridge of the cell wall. SrtAstaph, one of the
most characterized sortases, has found numerous applications in the semi-synthesis of protein
and peptide conjugates. While current studies have demonstrated the growing range of
applications for sortase A, the enzyme itself has seen very few improvements. In steady-state
kinetic analysis, the calculated K cat value of SrtAstaph was 2.27 × 10−5 s−1 indicative of its
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slow in-vitro turnover rate. Due to sortase’s relative inefficiency, several studies documented
the use of excessive amounts of the enzyme in vitro (>30µM) or reactions were incubated for
long periods.
Through the use of directed evolution, we aimed to improve the catalytic activity of
sortase A. Using random mutagenesis and an in vivo bacterial-based screen we isolated a
variant that showed a 13-fold increase in its catalytic efficiency when compared to wild-type.
This sortase mutant will enable more efficient labeling of LPETG-tagged substrates and will
provide further insight into the enzyme’s molecular mechanism of catalysis, which is
currently limited.

2	
  	
  

3	
  	
  

Chapter 1
Introduction
1.1 Protein Engineering
As of September 2011, the Genomes Online Database reported that 2940 genomes have
been completely sequenced ranging from the small genomes of several viruses and bacteria to
the much larger genomes of higher organisms (Genomes Online Database, 2011). Wholegenome sequencing projects are a major source of proteins with unknown function. Although the
molecular structures of over thirty thousand proteins have been solved, many proteins of known
sequence and structure still present challenges to the understanding of their function (i.e.
homologous proteins often have different functions). Many function prediction methods rely on
identifying similarity in sequence and structure by comparing proteins of known and unknown
function, however these methods only provide an approximation. Consequently, there is an
increasing demand for the specific incorporation of novel properties in proteins through protein
engineering (Whisstock, 2003).
Protein engineering is the process of altering the structure of an existing protein or
enzyme to improve its properties for applications in various fields. Redesigning the framework
of an existing enzyme to study molecular catalysis can increase our understanding of how the
enzyme functions (Kazlauskas et al., 2009; Bentley et al., 2007). There are two approaches for
engineering a protein: rational design and directed evolution. The rational redesign strategy
requires extensive knowledge of the protein’s structure and function to create desired changes. In
most cases, information is available for a few well-studied systems and even when it is available
it can still be difficult to predict the effects of various mutations. Directed or in vitro evolution
(requires no prior structural knowledge) is a method that mimics natural evolution. In this

1	
  	
  

strategy a randomly mutated protein undergoes a selection process from which variants that have
the desired qualities are chosen. A structure-based evolutionary approach, a combination of both
strategies, is when specific regions of a protein presumed to be critical for its function undergo
random mutagenesis, this can yield new information on the structure and interactions of the
protein (Kast et al., 1997).

1.2 Protein Ligation
To generate an altered enzyme, research often requires protein modifications that can be
difficult to prepare using standard recombinant techniques (Proft, 2010). As a result, various
methods have been developed in the past decade that ranges from peptide or protein fusions to
protein ligation.
Protein ligation is a powerful engineering method that allows synthetic and recombinant
polypeptides to be selectively joined (Figure 1.1). It allows the incorporation of fluorophores,
unnatural amino acids and other biochemical probes. Current ligation methods include: native
chemical ligation that relies on the efficiency of peptide thioester synthesis, which can be
problematic for larger polypeptides (Mao et al. 2004). Intein-based protein splicing suited for
single-site labeling is limited by the large tag size of the intein and the slow labeling
process(Proft, 2010). Common chemical labeling techniques targeting cysteine or lysine residues
are maleimides or N-hydroxysuccinimidyl esters lack the specificity needed for single-site
labeling within a given protein(Antos et. al 2009). Also, they cannot be used to modify cellular
proteins because they are residue specific and not site specific.
Chemical methods lack the precision of genetically encoded tags, therefore, enzyme-based
labeling techniques have been developed to exploit the specificity of enzymes to target chemical
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probes to single sites within a protein. Current enzyme-based ligations require the insertion of
recognition sequences that range from 6 to 38 residues and have varying degrees of labeling
selectivity based on the type of reporter molecule to be incorporated (Mao et al. 2004; Proft,
2010;Antos et. al 2009).

3	
  	
  

Figure 1.1: Ligation. Protein ligation occurs when the carboxyl group of one molecule reacts
with the amino group of another forming a covalent bond and causing the release of water.
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1.3 SORTASE
Sortase, an enzyme discovered in gram-positive bacteria, has recently been introduced as a
molecular stapler due to its specific ligation capability. It is a transpeptidase that covalently
anchors a variety of cell surface proteins to the cell wall (Marraffini et al. 2006). In 2007, using a
recombinant form of S. aureus sortase A, Boder et al. covalently linked a tagged green
fluorescent protein to chemically modified polystyrene beads via sortase-mediated
transpeptidation. Since then, sortase has been used for a variety of protein modifications:
incorporation of peptide analogues into proteins, generation of nucleic acid–peptide conjugates
and labeling of surface proteins(Figure 1.2) (Parthasarathy et al. 2007; Popp et al. 2007; Proft
2010).
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Figure 1.2: Sortase-catalyzed labeling. As a ligation tool, sortase has been used to link lipids in
mammalian cells, tag fluorophores, and to link carbohydrates to target proteins and also to
generate full-length receptors.
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Triglycine---*: carrys label of interest

Fc-tagged protein via an LPETG sequence that is cleaved
by sortase and undergoes transpeptidation reaction
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Sortase A
There are four classes of sortase, A, B, C, and D (Figure 1.3). Sortase A (SrtA), the
housekeeping sortase that is present on the cell surface of many gram-positive bacteria catalyzes
the covalent linkage of surface proteins to the peptidoglycan layer of the cell wall, a process
important for the pathogenesis of bacteria (Maresso et. al. 2008). Staphylococcus aureus, sortase
A (SrtAstaph), a 206-residue transpeptidase with an N-terminal membrane-spanning region and
a C-terminal catalytic domain, catalyzes the cleavage of the conserved sequence Leu-Pro-X-ThrGly (LPXTG) generating a transient acyl-intermediate then subsequently forming an amide bond
between the carboxyl-group of the threonine and the amino group of the pentaglycyl of lipid II
(Figure 1.4). Surface proteins recognized by sortase consists of a conserved LPXTG motif
(where X is any hydrophobic amino acid), followed by a hydrophobic domain and a positively
charged tail that help retain proteins in the membrane prior to the sortase-catalyzed anchoring
(Mazmanian et al. 1999). The catalytic domain of sortase adopts a conserved eight-stranded βbarrel fold (Figure 1.4). Using NMR and crystallography, the LPXTG or substrate binding site
has been shown to be formed by strands β4 /β7 and the β6/β7 loop. Although the substrate
specificity requirements of sortase have been well documented, the exact molecular basis for this
specificity is still unclear. Various reports linked the β6/β7 loop region of sortase with LPXTG
recognition. Substrate binding may occur through an induced-fit mechanism involving
conformational changes in the β6/β7 loop, because it is disordered in the absence of the
substrate. To explore specificity and molecular recognition in S. aureus sortase A (recognize
LPXTG motif) and its isoform sortase B (recognize NPQTN motif), Bentely et al. conducted
sequence analysis, mutagenesis, and domain swapping experiments. Both enzymes cleave after
the threonine residue followed by an amide bond formation between threonine and the
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pentaglycine cross-bridge of cell wall peptidoglycan. Altering the β6/β7 loop of both SrtA and
SrtB in domain swapping experiments converted SrtA into an NPQTN-cleaving enzyme with a
cleavage efficiency that was 11 times lower than the native SrtB. When the β6/β7 loop in SrtA
was replaced with a corresponding loop from SrtB the specificity profile of SrtA was lowered by
over 700,000-fold. These results indicate the β6/β7 loop has a major role in substrate recognition
(Bentley et al. 2007,Naik at al. 2006; Bentley 2008).
The versatility of sortase-mediated ligation is due to the tolerance of the enzyme for
substituents C-terminal to the acceptor nucleophile. During the transpeptidation reaction, the
acylation of the active site is rate limiting while the deacylation rate is nucleophile-dependent.
Since sortase-catalyzed hydrolysis of a LPETG peptide in the absence of triglycine is slow
(Huang et. al 2003), enhancing the nucleophilicity of the second substrate will improve the in
vitro turnover rate of sortase A.
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Figure 1.3: Family of Sortase. Based on sequence homology and distinct function within grampositive bacteria, there are four types of sortases: A,B,C, and D (each recognize unique substrate
motif). SrtA is the housekeeping sortase that function in cell wall anchoring of proteins involved
in immune evasion and recognizes LPXTG motif. SrtB anchor proteins involved in iron
acquisition, recognize NPXTG substrate motif. SrtC (LPXTG motif) assemble pili on the surface
of bacteria recognize and SrtD (LPNT) anchor proteins involved in sporulation (Maresso et al.
2008).
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Figure 1.4: Sortase A mediated transpeptidation in vivo. Cell wall-anchored surface proteins
of gram–positive bacteria encode a N-terminal signal peptide and a C-terminal cell wall sorting
signal. The N-terminal signal peptide is necessary for secretion of precursor proteins via the
secretory pathway. Signal peptidase cleaves the signal peptide allowing the translocation of
surface protein across the plasma membrane. The C-terminal sorting signal contains the LPXTG
motif that is cleaved by sortase between the threonine and the glycine residues forming a
thioester-linked acyl-enzyme intermediate. Resolution of the acyl-enzyme occurs through
nucleophilic attack of the amino group of the penta-glycine of lipid II to generate lipid II-linked
surface protein that is incorporated into the cell wall (Schneewind et. al 1999). The cell wall is
composed of glycan strands that have alternating disaccharides N-acetylmuramic acid and Nacetyl glucosamine(Heijenoort,2001)
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Figure 1.5: Structure of Sortase A residues 60–206 (SrtAΔN59). SrtAΔN59 adopts a β-barrel
fold, at the N terminus β1 strand is followed by a short hairpin and is antiparallel to β2. The β2
and β3 strands are parallel and form the lateral wall of the active site. β6 is connected to strand
β7 by a loop; positioned at the end of β7 is the active-site sulfhydryl group(Cys184) (Ilangovan
et al. 2001).
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LPETG substrate is labeled as blue stick figure binding to active site
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Kinetics
Catalysis occurs through a ping-pong mechanism that is initiated when sortase makes
hydrophobic contacts between residues in its β6/β7 loop and the LPXTG motif. This positions
active-site sulfhydryl residue (Cys-184) to attack the carbonyl carbon of threonine residue within
the LPXTG sorting signal, generating a thioester linkage between the enzyme and the substrate.
The thioacyl-enzyme intermediate is then resolved by a nucleophilic attack from an amino group
on the Gly5 (penta-glycine) cross-bridge of branched Lipid II(cell wall component). This leads to
covalent attachment of the N-terminal portion of the surface protein to Lipid II, from which it is
incorporated into the bacterial cell wall (Cossart et al. 2000; Antos 2008; Whisstock,
2003;Cossart 2004). A Gly3 peptide, which carries label of interest in in vitro sortase-mediated
ligations, mimics the terminal amine group of the penta-glycine branch portion of lipid II and is
used by sortase as a second substrate (or acceptor nucleophile) (Zong et al. 2004). One study
reported that the presence of NH2-Gly3 increased the affinity of sortase for its substrate and the
overall efficiency of the cleavage reaction (Ton-that 2000).
While recent studies have demonstrated the relative simplicity of sortase-mediated
transpeptidations and its versatility as a ligation tool (Parthasarathy et al. 2007; Popp et al. 2007;
Proft 2010). Marraffini et al. 2006), the enzyme is still limited by its slow catalytic activity.
Using a dabcyl-LPETGE-edans peptide (fluorescence of edans is quenched by dabcyl) a Kcat
value of 2.27 × 10−5 s−1 was calculated for the sortase-catalyzed transpeptidation reaction (Tonthat 2000).
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1.4 Protein Fragment Complementation Assay (PCA)
Many of the processes that occur in the cell, such as transcription and translation, are
mediated by non-covalently associated proteins or multi-enzyme complexes. Currently, there are
very few simple methods available for studying protein-protein interactions in vivo. One
common strategy is the yeast two-hybrid system; however, this approach may not be functional
in different parts of the cell. An alternative is the protein-fragment complementation assay
(PCA). In this method, fragments of a monomeric protein are generated, then the reassembly of
these fragments in vivo is detected (Pelletier et al. 1998). An important feature of the PCA
fragments is their inability to fold spontaneously, giving a false-positive signal that are may be
due to the differences in expression levels and or solubility rather than a protein–protein
interaction. Another key feature of this assay is that the molecular interactions are detected
directly and not through secondary events. Also, genes are expressed in vivo reflecting the native
state of the protein with the correct post-translational modifications (Michnick, 2003).
In designing a PCA, the protein must be small, monomeric, and its structure and function
information is available. One such enzyme is murine dihydrofolate reductase (mDHFR) that has
been studied extensively; it is a small 21 kDa monomeric protein of known structure. In the
absence of DHFR end products, DHFR activity can be monitored in vivo through cell survival. E.
coli DHFR is selectively inhibited by the anti-folate drug trimethoprim (Pelletier et al. 1998;
Remy et al. 2007).
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1.5 LIBRARY
1.5.1 Diversity and Random Mutagenesis
Evolution gives organisms the ability to adapt to harmful environmental changes by
continuously altering their genomes. However, not all changes are advantageous or beneficial,
some can have deleterious effects that can make the organism weaker and much more sensitive.
Through the natural selection process only variants that are fit to the new environment can
thrive; however, the changes occur at a slow pace. In the laboratory, directed molecular
evolution imitates the natural selection process by generating diverse sequences and selecting for
variants with improved properties at a much more accelerated rate (Wang et. al 2006). Successful
directed evolution experiments are the results of efficient library construction, and robust
screening. Before genetic engineering methods were introduced in an attempt to enhance the
performance of enzymes, microorganisms were treated with mutagenic chemicals or irradiated
with high-energy rays to generate variants, from which better performers were then screened and
selected (Jackel et al. 2008). Among the various evolutionary methods that have been used for in
vitro directed evolution are random mutagenesis and gene recombination (Wang et. al 2006;
Jackel et al. 2008; Labrou 2010)
Random mutagenesis is an important tool for generating enzymes or proteins with desired
or improved properties. There are several methods to generate genetic diversity via random
mutagenesis that includes passing cloned genes through mutator strains and error-prone
polymerase chain reaction (PCR) mutagenesis (Labrou 2010). Random mutagenesis
mechanisms can introduce five types of modifications: deletions or insertions of nucleotides,
transitions, transversions or inversions (Jackel et al. 2008). Site-directed mutagenesis, a
technique that allows amino acid sequences to be selectively altered, can also be used to modify
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the active site of an enzyme (Wang et al. 2006). Therefore, directed evolution (Figure 1.5) is an
alternative strategy to engineering a protein, especially for proteins whose structures are
unavailable or its structure and function remain to be established.
Error-prone PCR (epPCR) is a derivative of standard PCR and is a random mutagenesis
technique for introducing amino acid changes into proteins. Because of its simplicity and
versatility it is one of the most popular strategies when generating libraries in directed evolution
experiments. Mutations are introduced through the use of error-prone DNA polymerases; the
extent of mutations introduced can be altered by modifying PCR conditions (Wang et. al 2006;
Labrou 2010). Error-prone DNA polymerases lack proofreading activity and cannot remove
mismatched bases. In a study to examine the effects of mutation frequency by error-prone PCR
Daughtery et al. analyzed the frequency of clones that remain functional and gain-of-function
mutants. It was demonstrated that high affinity binding proteins could be readily isolated from
libraries generated by epPCR. Mutants with significantly higher affinity than the wild type were
well represented within the active fraction of the population. It was also shown that the
substitutions observed among the affinity improved clones were sometimes spatially distant from
the binding site, further proving that functional affinity could result from diverse mechanisms
(Daugherty et. al 2000).
Another method of introducing mutations is through the use of mutator strains of
bacteria. Compared to wild type bacteria, mutator strains can introduce a spectra of mutations at
a frequency of as much as100,000 times higher due to defects in DNA replication and repair.
XL1-Red mutator strains are deficient in three of the primary DNA repair pathways: mutS, mutD
and mutT. Dimeric MutS protein is part of the E.coli DNA repair system that corrects
mismatches arising in DNA. MutS binds specifically to mismatched base pairs and
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insertion/deletion mispairs of up to four nucleotides. It also participates in homologous
recombination and transcription-coupled repair (Wu et al. 1999). DNA polymerase III
holoenzyme of E.coli has 3'-5' exonuclease editing activity in addition to its polymerase activity.
Mutations affecting the fidelity of DNA replication in vivo and the activity of 3'-5' exonuclease
are found in the mutD gene (Scheuermann et al. 1984). The occurrence of the transversion
mutation A-T to C-G is enhanced in mutT mutants; the protein altered by mutt mutation
catalyzes the hydrolysis of dGTP to dGMP. Misincorporation was not observed in reactions with
mutT protein and misincorporation of dGMP was suppressed by adding the mutT protein to the
reaction mixture (Akiyama et al., 1989). The random mutation rate of the XL1-Red strain is
approximately 5000-fold higher than that of wild type E. coli. The limitation in using mutator
strains is its lower transformation efficiency and longer doubling time due to its impaired DNA
repair mechanism (Wang, 2006).

21	
  
	
  

Figure 1.6: Principles of Directed Evolution. The first step in directed evolution experiments is
to introduce mutations into a selected gene sequence generating a library of variants (A, B).
Next, the libraries are cloned into expression vectors and transformed into microbial hosts where
each cell receives a slightly different mutant(C, D). Using the appropriate screen, mutants will be
evaluated and selected (E). The screen employed or designed should have the ability to analyze a
large number of variants for the desired property and still detect or measure minor
improvements. The final step is to retrieve the DNA sequence of the mutant of interest, then
repeat the process of mutation and selection until the protein has accumulated enough variation
critical for its function (F) (Jackel et al. 2008).
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1.6 Fluorescence Resonance Transfer Energy
In fluorescence resonance energy transfer (FRET), an excited donor fluorophore transfers
its energy to an acceptor molecule by means of intermolecular long-range dipole–dipole
coupling. Fluorescence is the excitation of an electron to a higher energy level followed by its
return to the ground state with the emission of light that is dependent on the energy level to
which the electron is excited. When FRET occurs, there is a net loss in the energy of emitted
fluorescence from the donor and a net gain in the energy of emission by the acceptor. FRET
occurs when the emission spectrum of the donor significantly overlays the excitation spectrum of
the acceptor, and the distance between the donor and acceptor molecules is less than 100
angstroms (Å)(Olson et al. 2003). FRET measurements are highly efficient if the donor and
acceptor are positioned within the Förster radius (the distance at which half the excitation energy
of the donor is transferred to the acceptor, approximately 30–60 angstroms)(Sekar et al. 2003).
The efficiency of the transfer of this energy is inversely proportional to the sixth power of the
distance (r) between the donor and the acceptor making it a sensitive technique for investigating
a variety of biological phenomena that produce changes in molecular proximity (Sekar et al.
2003; Olson et al.2003).
The widely used donor and acceptor fluorophores for FRET studies in vivo are
autofluorescent proteins called green fluorescent protein (GFP) and its derivatives. GFP is a
26.9kDa protein that exhibits green fluorescence when exposed to blue light and, GFP tolerates
N- and C-terminal fusion to a variety of proteins (that are shown to retain their native function),
it functions as a fluorescent protein tag. GFP allows for a wide range of applications, when it is
used as a reporter of gene expression or as a way to measure protein-protein interactions. GFP
derivates or mutants that were developed specifically for FRET-based assays include cyan
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fluorescent protein and yellow fluorescent protein. These two color variants are often employed
in FRET experiments. When selecting GFPs as FRET pairs they should have: (i) sufficient
separation in excitation spectra for selective stimulation of the donor molecule, (ii) an overlap
between the emission spectrum of the donor and the excitation spectrum of the acceptor (iii)
Should have a separation in emission spectra between donor and acceptor to allow independent
measurement of the fluorescence of each fluorophore there (Sekar et al. 2003; Olson et
al.2003;Wang et al. 2008 ).
Using a flow cytometry-based FRET assay enables the assessment of interactions in large
cell numbers of cells. Fluorescence activated cell sorting (FACS) is sensitive, noninvasive, and
well suited to study protein interactions in living cells (Banning et al. 2010). When sorting cells
by FACS, instead of producing a value for the efficiency of FRET when comparing controls and
experimental samples, cells in positive control samples will display a higher intensity in the
FRET channel relative to the cells in the negative control samples that did not undergo FRET. A
gate is then drawn on the negative control graph to exclude negative control cells and to include
only cells exhibiting higher FRET intensity. The gating parameters set with the control samples
will then be applied to the plots of the experimental samples. If cells from the experimental
sample are reported intensities in the FRET gates set by the control parameters, this will indicate
that an in vivo interaction has occurred (Dye 2005).
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1.7 SPECIFIC AIMS
Aim 1: Develop Bacterial and Yeast-based assay to monitor SrtAstaphΔN59 activity
To monitor sortase activity we developed an Escherichia coli and a Saccharomyces
cerevisiae-based assay. In bacteria, we used an enzyme-based system that detects protein-protein
interactions in vivo upon functional reassembly of the enzyme’s dissected fragments (protein
fragment complementation assay-PCA). In this screen, cell survival relies on the sortasedependent reassembly of two fragments of the murine dihydrofolate reductase (mDHFR) protein,
reconstituting mDHFR enzyme activity and hence, cell survival. To develop the assay, we fused
LPETG and GGG peptide sequences (recognized and ligated specifically by SrtAstaph) to the
disassembled complementary N- and C- terminal domains of mDHFR. When sortase is
introduced, it will covalently link LPETG and GGG sequences, only cells expressing the fused
complementary fragments of mDHFR will survive when grown on a selective medium.
In the yeast-based screen, we use fluorescence resonance energy transfer (FRET)
between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) to monitor sortase
activity. To utilize CFP and YFP as fluorescent tags, we fused GGG peptide to CFP and the
LPETG peptide to YFP, which will allow direct monitoring of sortase activity in vivo.
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Aim 2: Screen mutant library for SrtAstaphΔN59 with increased catalytic efficiency
By introducing random mutations via error-prone pcr a library was generated and
screened using the developed assay. By evaluating the effects of the mutations we will gain
further insight into the enzyme’s molecular mechanism of catalysis.
Also, there has been a rise in antibiotic-resistant bacteria that are characterized by high
levels of virulence associated with surface proteins anchored by sortase (Maresso et al. 2008).
Such substrates function as adhesins, immune evasion factors, and transporters for nutrients
across the microbial cell wall envelope which are important for most pathogens to sustain an
infection (Maresso et al. 2008). Therefore, understanding how the enzyme functions can define
new targets for anti-infective therapy.
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Chapter 2
Protein-Fragment Complementation Assay
2.1 Developing bacterial-based assay to detect SrtAstaphΔN59 activity
To monitor sortase activity in bacteria, we used a simple protein-fragment
complementation assay (PCA) that detects the reassembly of active murine enzyme
dihydrofolate reductase (mDHFR) from two complementary fragments (Remy et al.
2007;Remy1999). In this in vivo assay, cell survival is dependent on sortase-mediated ligation of
LPETG and GGG peptides, that are covalently two linked to separately expressed and
independently folding complementary fragments of mDHFR, causing the reassembly of the
fragments and reconstitution of the enzyme’s activity (Figure 2.1). mDHFR is a 21-kDa
monomeric mouse protein that is highly homologous to E. coli DHFR (68% homology). It
catalyzes the synthesis of tetrahydrofolate (essential for thymidylate, purine nucleotides
biosynthesis), which is necessary for prokaryotic cell survival. Therefore, cells cannot grow on
minimal medium (nucleotide-free) in the absence of DHFR (Remy1999). To avoid endogenous
DHFR interference, minimal media was supplemented with the anti-folate drug trimethoprim,
which will selectively inhibits E.coli DHFR because mammalian murine DHFR has a lower
affinity (12,000- fold lower) than E.coli DHFR (Petellier 1998; Pelletier et al. 1998; Remy et al.
2007; Remy1999). Consequently, the survival of cells expressing fused mDHFR grown on
nucleotide depleted medium and in the presence of trimethoprim levels lethal to bacteria is an
efficient way of monitoring sortase activity.
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Figure 2.1: Schematic representation of the DHFR survival PCA. To monitor sortasemediated ligation, LPETG and GGG peptide sequences are fused to two complementary
fragments of mDHFR, so that the expression of sortase will induce the association of LPETG
and GGG sequences driving the reassembly of an active mDHFR enzyme.
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2.2 Method
2.2.1 Cloning
Sequence encoding mDHFR gene was dissected into two domains F-1, 2 and F-3
between residue 108 and 109 causing minimal disruption of the active site. To amplify sequences
of F [1,2] and F [3] domains genomic cDNA encoding full-length mDHR (Open Biosystems)
served as a template. Using complementary oligonucleotides LPETG peptide sequence was fused
to the F-1, 2 domain forming the N-terminal fragment of mDHFR and the GGG sequence was
fused to the F-3 domain forming the C-terminal fragment of mDHFR separated by a stop codon.
Duet vectors such as pETDuet, pRSFDuet, and pCFDuet are designed to co-express two target
proteins in E. coli. The N-terminal fragment was cloned into NdeI/XhoI (restriction enzymes
supplied by New England Biolabs) of multiple cloning site-1 (MCS-1) of pETDuet (Novagen)
and the C-terminal was cloned into the NcoI/HindIII sites of MCS-2, generating the pETDuetN/C-mDHFR construct. When induced, this construct will express the C-terminal domain
followed by the N-terminal domain as two separate peptides ensuring that mDHFR reassembly
can only be sortase-mediated.
Using a pRSF-2 Ek/LIC Cloning Kit (Novagen), SrtAstaphΔN59 was cloned into the pRSF
plasmid generating the pRSF-SrtAstaphΔN59 vector. Sortase sequence was amplified using
complementary primers designed to introduce LIC extensions using the pCON2 vector
containing sortase wild type sequence as a template. The PCR product was run on a 1% agarose
gel stained with ethidium bromide. A band traveling around the ~ 500 bp marker was excised
and DNA was extracted using a Gel Extraction Kit (Qiagen). Purified pcr product was treated
with LIC-qualified T4 DNA Polymerase in the presence of dATP and annealed to the Ek/LIC
vector. The resultant reaction was transformed into Mach-1 competent cells and grown on Luria
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Broth (LB) supplemented with 30µg/ml kanamycin. Clones were selected and DNA isolated
using a QIAprep miniprep spin Kit (Qiagen). When induced, the pRSF-SrtAstaphΔN59 vector
expresses sortase A the lacking the N-terminal 59 amino acids, enhancing solubility. The vector
contains a strong T7 lac promoter and has a very high copy number. All sequences were
confirmed through standard dideoxy sequencing chemistry.
2.2.2 Recombinant Protein Expression
To test protein expression of pRSF-SrtAstaphΔN59, the construct was transformed into
competent E.coli BL-21 (DE3) cells, plated on kanamycin and incubated at 37°C for 18 hrs.
Colonies were picked and propagated in liquid LB - kanamycin at 37°C, and induced with 1 mM
isopropyl-β-d-thiogalactopyranoside (IPTG) when the optical density of the cultures at 600nm
(OD600nm) was 0.6. After four hours of induction, cells were pelleted and lysed with Bugbuster (a
protein extraction reagent), crude lysates of induced and un-induced cells were separated on a
Coomassie Blue-stained 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) (Figure 2.2).
Next, the pRSF-SrtAstaphΔN59 and pETDuet-N/C-mDHFR constructs were cotransformed into BL-21 cells that were plated on ampicillin-kanamycin resistant plates. LB
cultures supplemented with 100 µg/ml ampicillin and 30 µg/ml kanamycin were grown at 37°C
and induced with IPTG. Serving as negative controls constructs expressing mDHFR, sortase and
an empty pRSF vector were transformed separately into BL-21 cells, and to serve as positive
control a vector expressing fused N and C terminal mDHFR fragments was also transformed.
Following the protocol by Remy et al. (Remy et al. 2007) cultures were pelleted and washed
three times with phosphate-buffered saline (PBS) before plating on M9 minimal medium plates
containing 100 µg/ml ampicillin, 30 µg/ml kanamycin and 10 µg/ml trimethoprim. Each
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transformation mixture was plated in the absence and presence of 1 mM IPTG and trimethoprim.
All plates were incubated at 37°C for 18 hrs.
2.3 Results
Only cells transformed with sortase and mDHFR fragments underwent normal cell
division in minimal medium supplemented with trimethoprim as shown in Figure 2.3A. No
growth was observed in the absence of sortase indicating that mDHFR fragment reassembly is
sortase-mediated. In the absence of trimethoprim (Figure 2.3 C, D), growth was observed for all
transformed cells. In the absence of IPTG induction, expression levels of the constructs
decreased significantly. When comparing the OD600nm of transformants propagated in liquid M9
minimal medium (Figure 2.4), cells co-transformed with sortase and mDHFR had higher OD in
the presence of trimethoprim. These results demonstrate that active mDHFR can be reassembled
when sortase covalently links the LPETG and GGG peptide sequences fused to the dissected
complementary N- and C-terminal domains of mDHFR which is indicated by the survival of
cells transformed with sortase on minimal media.
To confirm the presence of sortase in mDHFR positive cells, crude lysates of experimental
cultures including positive and negative controls (grown in absence of trimethoprim) were run on
a 12.5% SDS-PAGE gel and stained with Coomassie Blue (Figure 2.5 A, B). Although the
theoretical size of sortase is between 15-18kDa and mDHFR is 20-24kDa, when lysates of
induced and uninduced vectors were compared, over-expressed bands appeared between 21 and
31 kDa. To test if simultaneous co-transformation of mDHFR and sortase may interfere with the
expression of either vector, pETDuet-N/C-mDHFR construct was first transformed into Tuner
cells that were then made chemically competent before pRSF-SrtAstaphΔN59 vector was
transformed into the same cells. Tuner strains are lacZY deletion mutants of BL21, enabling one
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to adjust the levels of protein expression in a culture. Using a DHFR antibody, a blot of crude
lysates showed a band between 27 and 35 kDa (Figure 2.6 A). Same size bands appeared again
in blots of cells expressing only sortase probed with His-antibody (Figure 2.6 B and C). Cells
expressing only mDHFR probed with DHFR-antibody showed same size bands (Figure 2.6 D).
These results indicate that both sortase and mDHFR are the same size.
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Figure 2.2: Expression of wild-type sortase lacking 59 amino acids (SrtAΔN59). Crude lysate
of pRSF-SrtAstaphΔN59 expressed in BL21 cells separated on a Coomassie Blue stained 15 %
SDS-PAGE gel. Lanes 2-7 are lysates from cells induced with 1mM IPTG (4 hours) and lanes 810 are lysates of uninduced cells.
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Figure 2.3: E.coli Survival assay. (A) Cells transformed with mDHFR fragments and sortase
plated in the presence of trimethoprim and IPTG: (I) and (III) No growth was observed for
cells expressing only mDHFR fragments, (II) and (IV) Cells co-transformed with mDHFR
fragments and sortase survived the selection medium. (B) Growth was observed for positive
control, cells transformed with N and C terminal mDHFR fragments linked via an LPETG
sequence and plated in the presence of trimethoprim. (C) and (D) in the absence of
trimethoprim growth was observed for cells expressing only mDHFR fragments or an empty
pRSF vector that did not contain sortase sequence.
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Figure 2.4: E.coli survival assay in liquid culture. When comparing absorbances read at
600nm for cells transformed with DHFR fragments or sortase no changes were observed in the
absence of trimethoprim however cells did not grow in the presence of trimethoprim and absence
of sortase. Only cells co-transformed with DHFR and sortase or positive control(fused DHFR
fragments) were able to grow in the presence of trimethoprim.
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BL-21 cells expressing:
mDHFR only
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1.11
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1.521
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1.501

0.820

fused mDHFR fragments linked viaLPETG
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Figure 2.5: DHFR and Sortase Expression. To verify the presence of sortase and DHFR, cell
lysates obtained from minimal media plates shown in figure 2.3 were separated on 12.5%
Coomassie Blue stained SDS-PAGE gels. In lanes 3 and 5 bands for cells co-expressing DHFR
and sortase appear between 21kDa and 31 kDa, when induced lane 6 and 7 show intense bands
within the same kDa size
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FIGURE 2.6: Western of DHFR and Sortase expression. Lysates of cells co-expressing and
expressing sortase and DHFR separately were probed with DHFR and His antibodies (A) Bands
for BL21 cells co-transformed with cDNA encoding fragments of DHFR and with sortase
appeared at ~30kDa when expressed and probed with DHFR antibody. Also, Tuner cells
transformed with DHFR first, then made competent, before transforming sortase into the same
cells showed bands around ~30kDa. (B) Induced and uninduced BL-21 and Tuner cells
transformed with sortase only and probed with His antibody showed bands ~30 kDa. Different
clones of DHFR labeled C and A and sortase labeled G, A, J were used.
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Chapter 3
Library
3.1 Generation of SrtAstaphΔN59 library
To screen a library of SrtAstaphΔN59 mutants for the most catalytically efficient sortase,
random mutations were introduced by two different methods. To generate library using XL1-Red
Competent cells (Stratagene), the pRSF- SrtAstaphΔN59 vector was transformed into XL1-Red
cells, then plated on LB–kanamycin and incubated at 37°C. Colonies became visible 48 hours
later. To accumulate mutations, bacteria were propagated in Terrific broth media (TB) in the
presence of kanamycin until an OD600nm of 1.0, aliquots were removed, diluted, then propagated,
this was repeated for several rounds (five weeks). DNA was isolated using Qiagen midi-prep kits
and sequenced. However, when compared to the wild type sequence, no mutations in the coding
region for sortase A ΔN59 were found.
At the same time the GeneMorph II random mutagenesis kit (Stratagene) was used as an
alternative method. GeneMorph generates amino acid substitutions (mutation rates of 1–16
mutations per kb of cDNA) in proteins through PCR. The kit features Mutazyme DNA
polymerase, an error-prone polymerase that produces all possible transition and transversion
mutations.
While many different cloning systems have been developed, the one with the highest
level of flexibility is the Gateway cloning system, which allows transfer of DNA fragments
between different vectors while maintaining the reading frame. This system uses in vitro sitespecific recombination, generating clones through a two-step process: the first is an
intermolecular recombination (called BP reaction) producing an entry clone; the second is an
intramolecular recombination reaction generating an expression clone through a reaction called
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LR. In a BP reaction the gene of interest is amplified with attB1 and attB2 tagged primers that
are introduced into a donor vector carrying attP1 and attP2 sites catalyzed by BP clonase
resulting in the formation of an entry clone that contains the gene of interest flanked by attL1 and
2 sites (Figure 3.1). The second step is the generation of an expression clone (a destination vector
carrying gene of interest) through a recombination reaction between attL sites (found in donor
vector) and attR sites (found in destination vector) catalyzed by LR clonase (Esposito et al. 2009;
Suzuki, 2005).
3.2 Method and Results
3.2.1 Cloning mutant library
Using pRSF-SrtAstaphΔN59 vector was used as a template in a 50 µl reaction mixture that
contained the following: 41.5 µl of deionized water, 5 µl of 10× Mutazyme II reaction buffer, 1
µl of 100 mM dNTP mix, 0.5 µl of forward and reverse primers (each at 100µM), 1 µl of
Mutazyme II DNA polymerase and 0.28 µl template (100 ng/µl). Then, the following PCR
program was run: denaturing temperature at 95°C for 4 minutes, annealing temperature at 56°C
for 30 seconds and extension at 68°C for 1minute for a total of 30 cycles. The PCR product
obtained was used as a template for several rounds of pcr to accumulate more mutations.
Using the gateway-cloning method, the sortase mutant library generated via Genemorph
was cloned into pDEST expression vector. The library was tagged with attB1 and 2 sites using
SrtAattB1 forward (ggggacaagtttgtacaaaaaagcaggctcgcaagctaaacctcaaattccg) and SrtAattB2
reverse (ggggaccactttgtacaagaaagctgggttttatttgacttctgtagctac) as primers, for recombination with
pDonor 221 vectors in the presence of BP clonase. After incubating at 25°C for one hour, 1 µl of
BP reaction mix was electroplated using a BioRad GenePulser Xcell at 1800 volts and the
suspension was plated on kanamycin resistant plates. pDonor colonies were picked, propagated
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in liquid LB then DNA was isolated using plasmid midi kit (Qiagen). Next, pDonor-library
vector was incubated with pDEST17 vector at 25°C for 1hour in the presence of LR clonase.
One µl of the reaction mixture was electroporated and plated on kanamycin resistance plates
from which colonies were picked and DNA was isolated. To test the quality of the library and the
distribution of mutations, how many clones were sequenced at random. Results showed the
presence of various mutations for different clones. The cloning process was repeated and a total
of 70 transformation reactions were performed yielding a library of 2.1x 107 transformants.
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Figure 3.1: Gateway cloning two-step process: BP and LR reactions. Two reactions
constitute gateway cloning technology, the first step is generation of an entry clone: PCRproduct with flanking attB sites and pDONR 221 vector containing attP sites incubated in the
presence of BP clonase creating an entry clone that contains attL sites flanking gene of interest.
The second step is formation of an expression clone: entry clone containing attL sites and
pDEST vector containing attR sites are mixed and incubated in the presence of LR clonase
generating expression clone containing attB sites.
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3.3 Screen Library using PCA
The pDEST 17 vectors carrying the library is ColE1 origin based and ampicillin-resistant;
it is incompatible with pETDuet carrying DHFR fragments. To maintain multiple vectors in E.
coli it is important that the plasmids possess compatible origins of replication and different
antibiotic resistance genes for selection. If two plasmids sharing common origins of replication
are used to co-transform E. coli, the replication of one plasmid will be inhibited because of an
RNA antisense mechanism, which causes plasmid segregation within the population. Compatible
plasmids stably coexist in a single cell by occupying different sub-cellular locations within the
bacterium (Tolia et al. 2006). Therefore, plasmids sharing common origins of replication or
antibiotic resistance genes should not be used for the co-expression of two proteins (Tolia et al.
2006). Therefore, the N and C terminal fragments of mDHFR were moved from petDuet vector
and cloned into pCFduet that carries streptomycin resistance, generating a pCFDuet-N/CmDHFR construct (similar results with pCFDuet were obtained to chapter 2).
3.4 Method and Results
3.4.1 Expressing and Screening Library
The pDest vectors containing mutant sortase library were co-transformed with pCFduetN/C-mDHFR construct into BL-21 cells and propagated in liquid LB- media at 37°C. When cells
reached an OD600nm of 0.6, the cultures were induced for five hours with 1 mM IPTG, and then
the bacteria were pelleted and washed several times with PBS. After last wash, the pellet was
suspended in PBS, and the cells were used to inoculate 50 mL of liquid M9 minimal media
cultures supplemented with 50-µg/ml streptomycin, 100 µg/ml ampicillin, 10 µg/ml trimethoprim
and 1mM IPTG. Once cultures reached an OD600nm of one, one mL aliquots were removed and
diluted into new 50mL cultures that were grown for 24 hours and then diluted 1:50 and grown
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for another 24 hours. Aliquots removed were used to inoculate ampicillin resistant liquid LB
cultures that were then mini-prepped, transformed into Mach-1 cells and plated on ampicillin.
Single colonies were isolated, propagated in liquid cultures, DNA isolated and then sequenced.
After sequence analysis, clones were selected for another round of PCR reactions using
mutazyme and the process was repeated. After the second round of cultivation, aliquots from
50mL cultures were removed after 8, 12 and 24-hour time points and serial dilutions (10-1 -10-6)
were performed, followed by more sequencing and PCR reactions (Figure 3.2). In the last two
weeks of culture propagation (total of five weeks), trimethoprim concentrations were increased
from 10 µg/ml to 30 µg/ml, 60 µg/ml and 100 µg/ml to avoid possible interference of bacterial
DHFR that may have developed resistance to low trimethoprim concentrations. A total of 230
clones were sequenced.

51	
  
	
  

Figure 3.2: Sortase Evolution. The gene-morph library was co-transformed with the N and Cterminal DHFR fragments into BL-21 cells and propagated in liquid 50mL M9 minimal media
cultures supplemented with 50µg/ml streptomycin, 100µg/ml ampicillin, 10µg/ml trimethoprim
and 1 mM IPTG. One mL aliquots were diluted 1:50 into new 50mL cultures that were grown for
24 hours and then diluted and grown for another 24 hours. After sequence analysis clones were
selected as templates for more PCR reactions After the second round of propagation in 50mL
cultures, aliquots were removed after 8, 12 and 24-hour time points, serial dilutions were
performed, followed by sequencing and more PCR reactions.
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3.4.2 Results
Sequencing analysis revealed the predominance of eight mutations as shown in Figure 3.3
and 3.4. Four of the eight mutated residues are located at the surface of the enzyme in close
proximity to the active site (Figure 3.6). The following are residues found in the active site: A92,
P94, L97, A118, H120, I182, C184, W194. Residues between K162 – G174 form the disordered
loop involved in substrate recognition. The mutations occurred at residues Pro-94, Ala-104, Glu105, Gly-167 and (Figure 3.4). Polar uncharged PRO-94 was mutated into positively charged
His, nonpolar Ala-104 replaced with polar uncharged Thr, negatively charged Glu-105 was
substituted with negatively charged Asp, nonpolar Gly-167 was mutated into negatively charged
Glu and polar uncharged Gln-172 was replaced with His. Although residue GLY-92 was mutated
into a stop codon, TGA may be suppressed by UGA Trp tRNA or mutant expressed is truncated
(Macbeath et. al 1998).
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Figure 3.3: Mutations. Sequences of clones isolated after several rounds of propagation in
liquid cultures and PCR reactions.
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Figure 3.4: Predominant Mutations. Table lists the mutated residues of isolated sortase mutant
when compared to wild-type. Four of the eight mutations occurred in residues that were in close
proximity to the active site. TGA* indicates stop codon is converted into tryptophan.
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Wild-type

Mutant

Nucleotide

Amino Acid

Nucleotide

Amino Acid

TCG

Ser – 70

TCA

Ser

GGA

Gly – 90

TGA*
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CCT

Pro – 94

CAT

His

GCA

Ala – 104

ACA

Thr

GAA

Glu– 105

GAT

Asp

CCT

Pro – 163

CCA

Pro

GGA

Gly – 167

GAA

Glu

CAA

Gln – 172

CAT

His
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Figure 3.5: Frequency of mutations. Comparing the frequency of the eight predominant
mutations.
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Figure 3.6: Crystal structure of Sortase A in complex with LPETG substrate. Mutations that
occurred in close proximity to the substrate-binding site, highlighted in red are Pro-94 which lies
at the N terminus of helix 1, Ala-104 and Glu-105 are on a loop that protrudes into the active
site, Gly-167 and Gln-172 are found in the region between β6/β7 strands that are involved in
LPETG substrate (stick diagram) recognition. Highlighted in yellow is active site Cys-184.
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Figure 3.7: Kinetic Model. Catalysis occurs through a ping-pong mechnism that is intiated
when sortase makes hydrohpoic contacts between residues in its β6/β7 loop and the LPETG
motif. The scissile T-G peptide bond is positioned between active site Cys184 and Arg197 residues
and at a greater distance from the imidazolium side chain of His120 (all three residues are
conserved). Active-site sulfhydryl residue (Cys184) attacks the carbonyl carbon threnonine
residue within the LPETG sorting signal, generating a theioester linkage between the enzyme
and the substrate. The thioacyl-enzyme intermediate is then resolved by a nucleophilic attack
from an amino group on the Gly5 (penta-glycine) cross-bridge of branched Lipid II. (Cossart at
al. 2000; Antos 2008; Whisstock, 2003; Cossart 2004).
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3.5 Evaluate activity of Mutant
3.5.1 Isolating and purifying mutant - Method
The selected clone was transformed into BL-21 cells and grown overnight in 10 mL of
LB cultures (incoluated with ampicillin) at 37°C to be used as starter culture for six liters the
next day. When OD600nm of 0.6 was reached, cells were induced for eight hours with 1mM IPTG.
Cultures were then centrifuged at 8000 xg for 15 minutes and re-suspended in 20 mM Tris-HCl,
300 mM NaCl at pH 8.0 (Buffer A). The cells were lysed by three passes through emulsifier at
20,000 psi then spun at 8000 xg for 30 minutes to remove cell debris. The lysate was applied to a
5 mL pre-packed HisTrap nickel agarose column (GE) washed with Buffer A. His-tagged protein
was eluted using a linear gradient from 0mM imidazole in Buffer A to 500mM imidazole in
Buffer B (500mM Imidazole, 20mM Tris-HCl, 300 mM NaCl pH 8.0) on a FPLC system.
Fractions containing the sortase mutant (isoelectric point is 8) were pooled and separated on
cation exchanger mono S(Sulphonate) column that was washed with 10 mM MES(2-NMorpholino ethane sulphonic acid, pH 6.0) buffer. The enzyme was eluted using a 10mL
gradient of buffer containing 10mM MES and 150 mM NaCl. Fractions were collected and
pooled for further separation on a Superdex 200 gel filtration column that was equilibrated with
Buffer A. Protein concentration was quantified using the Bradford assay (BioRad) and purity
was assessed on a 12.5% SDS-PAGE gel.
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Figure 3.8: Purification of SrtA mutant. Following separation on Mono S column, SrtA
fractions were separated on 12.5% SDS-PAGE gel and intense bands appeared between 21 and
31kDa.
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Figure 3.9: Wild-type sortase and mutant. When fractions of the mutant were pooled and
compared to wild-type on 12.5% Commassie stained SDS-PAGE gel, both were running
between 21 and 31kDa.
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3.5.3 Re-cloning and expressing mutant- Method/Result
To test mutant expression in a high copy vector (pRSF), SrtA-LIC for and rev primers
were used to amplify the mutated sequence from pDEST vector carrying the SrtA mutant. The
PCR product was gel-purified and cloned into the pRSF vector and transformed into BL-21 cells.
Six liters of LB were induced and lysed using the emulsifier then purified via a His-column,
collected fractions were quantified using Bradford (13.8 µg/µl) and separated on a Coomassiestained 12.5% SDS-PAGE (Figure 3.10)
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Figure 3.10: Purification of mutant in pRSF vector. Fractions collected from HisTrap column
and separated on 12.5% SDS-PAGE gel.
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3.5.2 Fluorescence assay to assess mutant activity – Method/Result
Fluorescence of the Edans fluorophore (e) within peptide d-QALPETGEE-e is quenched
by the close proximity of Dabcyl (d). When the peptide is cleaved by sortase and the fluorophore
is separated from Dabcyl, during the transpeptidation reaction, an increase in fluorescence is
observed (Figure 3.11). The activity of sortase mutants was measured in 384-well plate in a
volume of 20 µl at 25°C. All assays were prepared (following protocol listed in (ton-that et al.,
2000)) in sortase reaction buffer, which contained 50 mM Tris/HCl pH 7.5, 5 mM CaCl2, 150
mM NaCl and 1 mM DTT. The following solutions were prepared on ice: 5 µM of enzyme
solution, 1 µM and 10 µM of substrate peptide solution and 100 µM of Gly5 (competing
nucleophile). The concentration of enzyme and nucleophile were kept the same while substrate
concentration (0 µM to 10 µM) varied, the assays were initiated by the addition of enzyme. The
wells were read using a Tecan microplate reader equipped with Magellan software to analyze
time profiles of fluorescence intensity in each well. With 50 readings per well for each
measurement and a 0.1s pause between each movement and reading, the excitation and emission
wavelengths were set at 350 nm and 495 nm, with a bandwidth of 5 nm. The data from the plate
scanner was expressed as relative fluorescence units (RFUs) that were plotted against time.
When comparing the RFU readings of the mutant to negative control (Cys184Ala and
Cys184Ser) and wild-type, significant differences in activity were detected as shown in Figure
3.12.
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Figure 3.11: FRET-cleavage assay. To measure activity of sortase an LPETG peptide with an
Edans fluorophore on the C-terminal and Dabcyl on the N-terminal was used. Fluorescence of
the Edans within peptide is quenched by the close proximity of Dabycl. During transpeptidation
reaction, the peptide is cleaved by sortase and the fluorophore is separated from Dabcyl, and as a
result an increase in fluorescence is observed.
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Figure 3.12: Fluorescence assay for enzyme activity. Profiles of sortase activity expressed as
RFU (relative fluorescence unit) versus time. (A) Blank (B) Wild-type, (C) Mutant
(Gly90,Pro94,Ala104,Glu105,Pro163,Gly167,Gln172) and (D) Negative control (Cys184 Ala).
RFU values for wild-type are between 40,000 and 50,000 and mutant RFU values are between
60,000 and 70,000.
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Figure 3.13: Kinetic characterization of mutants. Kinetic parameters Vmax, Km and kcat
were calculated by fitting initial reaction rates to the Michaelis-Menten equation.
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kcat (s-1)
Wild-type

Km (µM)

kcat/Km (M-1 s-1)

1.3 ± 0.1

8.1 ± 0.3

150 ± 20

Mutant-P94H/A104T/105D/G167E/Q172H

3.15 ± 0.3

1.6 ± 0.5

2000 ± 100

Mutant-P94H

1.5 ± 0.06

4.2 ± 0.1

400 ± 70

Mutant-P94H/A104T/E104D

1.6 ± 0.2

3.0 ± 0.2

540 ± 50

Mutant-P94H/A104T/E105D/G167E

2.1 ± 0.5

1.9 ± 0.03

1100 ± 200
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Chapter 4
FRET-based Assay
4.1 Developing yeast-based assay to detect SrtAstaphΔN59 activity
To monitor SrtAstaphΔN59 activity in yeast using FRET signal between CFP and YFP, the
LPETG peptide sequence was covalently linked to CFP and M-GGG (M- methionine
aminopeptidase) to YFP then cloned into the MCS-1 and 2 of yeast vector pESC, generating a
pESC-CFP-LPETG-YFP-GGG construct. The pESC vectors are designed to express high levels
of eukaryotic proteins in S. cerevisiae; they contain selectable markers GAL1 and GAL10
promoters in opposite orientation allowing co-expression of two genes in the same cell. These
promoters are tightly repressed when glucose is present in the media and are highly induced
when galactose is present. In this assay CFP and YFP function as a donor-acceptor pair for
FRET, excitation of the donor CFP molecule will lead to emission from the acceptor YFP
molecule, provided that the proteins are in close proximity (<10 nm) for energy transfer to occur
as illustrated in figure 4.1. The CFP-YFP pairs are suitable for FRET due to their dipole
orientation, sufficient florescence lifetime and the emission spectrum of CFP significantly
overlaps with the excitation spectrum of YFP. FRET can therefore be used to monitor direct
protein-protein interactions between YFP and CFP fusion proteins in vivo. To analyze FRET
between CFP and YFP using flow cytomtery three basic fluorescence measurements are used for
the analysis of FRET: YFP fluorescence, CFP fluorescence, and the FRET channel which
measures the amount of YFP fluorescence produced during the excitation of CFP. Ideally, the
light detected in the FRET channel would come only from sensitized emission (emission induced
by FRET from donor to acceptor) however, because of the broad spectral profiles of CFP and
YFP, other sources of fluorescence can also contribute to this signal. To minimize the effect of
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bleed-through on FRET assessment, compensatory techniques using mathematical correction
factors derived from fluorescence measurements made in control cells are applied (Sekar et al.
2003; Olson et al. 2003; Dye 2005).
4.2 Method and Results
To compensate CFP bleed-through into the YFP channel, CFP and YFP were cloned
separately into pESC yeast vectors; cells expressing these vectors are used to set the parameters
of the flow cytometer. To generate a positive control YFP and CFP were fused via an LPETG
sequence (YFP-LPETG-CFP) then cloned into a pESC-ura vector forming the pESC-ura-YFPLPETG-CFP-GGG construct. To examine the expression of the fluorescently tagged peptide
sequences using a leica confocal laser-scanning microscope as shown in figure 4.2, pESC
plasmids were transformed into competent YPH-499 yeast cells (haploid strain that contains a
URA-mutation) then transformants were plated on synthetic dextrose minimal medium (SD
dropout media) and incubated at 30°C for 48hrs. To induce cell expression using galactose, cells
grown in SD media were then transferred into synthetic galactose minimal medium (SG dropout
media).
To detect FRET signal and measure its efficiency in cells expressing the positive control
pESC-ura-YFP-LPETG-CFP-GGG construct by using donor quenching as a measurement of
FRET, the acceptor photo-bleaching methodology on the confocal microscope was used. During
FRET, the energy of the CFP fluorophore is transferred to the YFP fluorophore rather than being
emitted as CFP fluorescence. FRET can be observed as a change in the amount of CFP
fluorescence that results from the introduction or removal of its YFP counterpart (Dye 2005).
Therefore, there should be an increase in CFP fluorescence upon the inactivation of YFP. First,
YFP and CFP crosstalk into the FRET channel was determined using controls cells expressing
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CFP and YFP independently. The fusion positive control was excited using 458nm and 514nm
wavelengths and emission was detected at 465-505nm for CFP and 525-600nm for YFP, using
these settings we were able to confirm that the cells were FRET-positive with an average of 15%
efficiency (Figure 4.2).
To evaluate activity of sortase, yeast cells from SG media were pelleted, lysed
using Zymolase (zymo research) and probed with GFP antibody (Figure 4.3). When analyzed,
intense bands of unlinked CFP and YFP fragments appeared around 30 kDa for lysates of
controls and experimental cultures, no bands appeared for negative control (cells expressing
sortase only), bands for fused CFP and YFP (positive control) appeared around ~ 60-70 kDa.
Cultures expressing experimental vector showed a ~ 70 kDa band only in the presence of sortase,
indicating that sortase is ligating the fluorescent proteins.
To prepare samples for flow cytometry analysis, cells were pelleted, washed and
resuspended in PBS to a cell density of 1 × 107 cells/ml. Cells expressing CFP, YFP controls
individually, in combination (fusion positive control) and cells co-expressed with sortase and
experimental vector were analyzed on FACS Aria (BD Bioscience). Fluorescence intensities
detected were plotted as CFP versus YFP signal (Figure 4.4), when experimental vector was coexpressed with sortase a signal is observed in the YFP channel indicating energy transfer
however because laser used was near UV (~375nm) and not a violet laser, CFP was not
sufficiently excited (only 40%). Preliminary data demonstrated that fluorescence of experimental
cells was different in the presence and absence of sortase, further experiments with sufficient
CFP excitation is needed to confirm FRET measurement.
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Figure 4.1: An illustration of FRET-based Assay: CFP and YFP can function as a donoracceptor pair for FRET in which excitation of CFP leads to emission from YFP. To detect
sortase activity in yeast cells, LPETG was fused to CFP and GGG was fused to YFP.
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Figure 4.2: Evaluation of pESC expression vectors. Using the acceptor photo-bleaching
methodology on the Leica confocal laser scanning microscope, FRET measurement on YPH-499
cells transformed with positive control pESC-ura- YFP-LPETG-GGG-CFP construct had an
average of 15% efficiency. A) Cells expressing YFP and B) Cells expressing CFP
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B)
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Figure 4.3: Activity of Wild-type Sortase in Yeast cells. Lysates of induced YPH-499 cells
transformed with the following vectors and probed with GFP antibody: CFP and YFP fragments
displayed a band that is ~30kDa (lanes1-9), positive control fused YFP-LPETG-GGG-CFP
displayed a ~60-70 kDa (lanes 7 and 9) band and experimental vector expressing LPETG fused
to CFP and GGG fused to YFP co-expressed with sortase displayed an ~60 kDa and ~30 kDa
bands(lanes1 and 4).
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7
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Figure 4.4: FRET measurement by Flow cytometry. Dot-plots of yeast cells comparing YFP
vs. CFP fluorescence. To measure FRET, YPH-499 cells were transformed with controls CFP
only, YFP only, CFP-YFP fusion and experimental vectors (express unlinked YFP and CFP
fragments) with and without sortase and analyzed on a FACS Aria flow cytometer.
A) Plot of cells expressing CFP only
B) YFP only
C) Wt SrtA only
D) Experimental vector (B) + 20% of cells expressing positive control
E) Experimental vector (clone B) only
F) Experimental vector (B) + wt SrtA
G) Experimental vector (clone D) only
H) Experimental vector (D) + wt SrtA
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Chapter 5
Conclusion
To enhance the catalytic activity of sortase, we generated a library of sortase variants by
introducing random mutations through error- prone pcr. We developed a bacterial-based assay to
monitor the enzyme’s activity and to screen the library for mutants with improved catalytic
efficiency. After several rounds of propagation in minimal media, we isolated mutants that have
higher catalytic activities than wild type. Independently, the mutations showed a slight increase
in kcat and significant decrease in Km values. However, cumulatively the mutations produced a
two-fold increase in kcat and 13-fold increase in kcat/km values.
Using an in vivo assay to direct the evolution of sortase, selections were based on a liquid
medium, therefore only the most abundant variants or clones are characterized, to increase
selection pressure serial dilutions were performed and incubation periods were shortened.
Through site-directed mutagenesis experiments, several studies demonstrated that Cys 184 and
His 120 are essential for catalysis. Kinetic assessments of clones with mutated Cys184 and
His120 positions showed significant decrease in catalytic activity (for His mutations) relative to
wild-type sortase or abolished activity (for Cys mutants). These findings are consistent with the
proposed mechanism in which Cys acts as the active site nucleophile and His participates as an
acid or base during catalysis.
The essential mutations (that caused changes in kcat and Km values) appeared early in the
screen and they mapped to the recognition of substrate rather than the acid/base or catalytic
residues because the screen selects for clones with high catalytic efficiency, mutated catalytic
residues will have a much lower efficiency and therefore cells carrying these clones will die out.
The kinetic analysis of mutants that we isolated showed significant decrease in Km values
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indicating that the mutations effect substrate recognition. Mutations that caused increase in kcat
and decrease in km are P94His, Ala104Thr, Glu105Asp, Gly167Glu and Gln172His. Given the
position of Pro94His (located across from Cys184 nucleophile) the histidine mutation may have
a role in stabilizing the oxyanion acyl intermediate(Bentley 2008). Ala104, Glu105 and Gly167
are residue positions involved in substrate recognition. Glu105Asp is one of the residues that
form the Ca2+ binding site (Naik et al. 2006); when calcium binds, it decreases the flexibility of
the β6−β7 loop and locks it into the correct confirmation allowing substrate binding. In bound
LPETG-SrtA structures, residue Gln172His protrudes into the active site and is in a position to
form hydrogen bonds to the backbone of the Leu-Pro amide bond in the substrate. Gln172 is also
one of the residues involved in calcium binding; therefore, the presence of histidine may enhance
binding of calcium and stimulate the enzyme’s activity.
Through kinetic analysis, previous studies have shown that the rate of sortase- mediated
cleavage at the LPXTG motif increased in the presence of weak nucleophiles NH2-Gly, NH2Gly2, or NH2-Gly3(Ton-That 2000). The rate of substrate cleavage depended on the nature of
the added nucleophile, when compared the fastest substrate cleavage occurred in the presence of
NH2-Gly5. The Pro94His mutation may increase the affinity of sortase for second substrate as
well as the overall efficiency of the cleavage reaction because the histidine mutation might play a
role in deprotonating the incoming secondary nucleophile and help stabilize the formation of
acyl intermediate, via electrostatic interactions or hydrogen bond to orient the LPXTG substrate
for catalysis. Another group isolated a sortase mutant that had a 3-fold increase in its catalytic
activity compared to wild-type, the following mutations caused changes in the enzyme’s activity:
Pro94Ser, Asp160Asn, Asp165Ala and Lys196Thr. Asp160Asn and Asp165Ala are one residues
that form the disordered loop and are involved in substrate recognition (Liu et al. 2011).
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Mutation into Asn and Ala may have enhanced the hydrophobic interactions between the
residues on the loop and leucine-proline segment of the LPETG substrate. In addition to
stabilization of the oxyanion in the transition state, it is possible that Arg197 also facilitates the
departure of the substrate-leaving group or activates the incoming nucleophile and therefore a
Lys196Thr mutation may enhance enzyme-substrate binding by facilitating the proper
orientation of the substrate for the nucleophilic attack.
In summary, the simplicity, high-specificity and versatility of sortase- mediated
transpeptidation reactions offers an efficient method for attaching diverse array of probes to
target proteins. Therefore, improving sortase’s efficiency and altering its substrate specificity
will enhance its wide applicability.
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